# Oxford Bioscience Partners: portfolio, investments and team

> Oxford Bioscience Partners is a growth equity based in United States. 73 investments on record, latest May 2014. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/oxford-bioscience-partners (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Oxford Bioscience Partners

Last cheque observed May 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Quiet Growth equity Website unconfirmed

Series B Series C Series A Information Technology Logistics

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 73 on record

Since the last cheque **4553** days **00** hrs **00** min **00** sec

Median round **$15M** Rounds led **0 of 73** Sole investor **1 rounds** Exits **23 from the portfolio** Mostly in **United States, 100%**

Pitch Oxford Bioscience Partners

## Oxford Bioscience Partners highlights

- 01 73 rounds on record
- 02 Mostly Series B and Series C: 57% of its rounds
- 03 Sole investor in 1 rounds, median $2.0M
- 04 23 exits from the portfolio

## What they do

- **Type:** Growth equity (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Information Technology Logistics
- **Based in:** United States
- **Cold pitches:** Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. [Tell us the right one](https://millionrounds.com/corrections?slug=oxford-bioscience-partners).

## The record

Every round we can evidence, newest first **73 appearances**

- **2014** 1 round
- **May** **[CardioFocus](https://millionrounds.com/company/cardiofocus)** Debt · US **$2.4M** With 7 others
- **2013** 2 rounds
- **Sept** **[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Debt · US · canadianprivateequity.com **$12M** With 2 others
- **Jul** **[Dicerna Pharmaceuticals](https://millionrounds.com/company/dicerna-pharmaceuticals)** Series C · US · finsmes.com **$60M** With 8 others
- **2012** 2 rounds
- **May** **[Mitralign](https://millionrounds.com/company/mitralign)** Series D · US · finsmes.com **$35M** With 5 others
- **Jan** **[Glori Energy](https://millionrounds.com/company/glori-energy)** Series C · US · businesswire.com **$20M** With 5 others
- **2011** 1 round
- **Feb** **[CardioFocus](https://millionrounds.com/company/cardiofocus)** Series C · US · finance.yahoo.com **$31M** With 8 others
- **2010** 5 rounds
- **Sept** **[SuperDimension](https://millionrounds.com/company/superdimension)** Venture · US · superdimension.com **$25M** With 3 others
- **Apr** **[Tragara](https://millionrounds.com/company/tragara)** Series B · US · onbiovc.com **$5.0M** With 4 others
- **Mar** **[Seahorse Bioscience](https://millionrounds.com/company/seahorse-bioscience)** Series D · US · onbiovc.com **$5.0M** With 6 others
- **Jan** **[Molecular Biometrics](https://millionrounds.com/company/molecular-biometrics)** Series B · US · finsmes.com **$13M** With 2 others
- **Jan** **[CircuLite](https://millionrounds.com/company/circulite)** Series C · US · finsmes.com **$33M** With 4 others
- **2009** 8 rounds
- **Nov** **[Cambrios Technologies](https://millionrounds.com/company/cambrios-technologies)** Series D · US · deals.venturebeat.com **$15M** With 13 others
- **Oct** **[Coherex Medical](https://millionrounds.com/company/coherex-medical)** Series B · US · onbiovc.com **$17M** With 2 others
- **Jun** **[VaxInnate](https://millionrounds.com/company/vaxinnate)** Series D · US · onbiovc.com **$30M** With 6 others
- **May** **[Elixir Pharmaceuticals](https://millionrounds.com/company/elixir-pharmaceuticals)** Series D · US · onbiovc.com **$12M** With 4 others
- **Mar** **[Claros Diagnostics](https://millionrounds.com/company/claros-diagnostics)** Series B · US · pehub.com **$4.0M** With 3 others
- **Mar** **[Seahorse Bioscience](https://millionrounds.com/company/seahorse-bioscience)** Series D · US · masshightech.com **$6.0M** With 6 others
- **Mar** **[Pathway Medical Technologies](https://millionrounds.com/company/pathway-medical-technologies)** Series D · US · venturebeat.com **$43M** With 4 others
- **Jan** **[Melinta](https://millionrounds.com/company/melinta)** Growth · US · rib-x.com **$25M** With 7 others
- **2008** 5 rounds
- **Dec** **[Luca Technologies](https://millionrounds.com/company/luca-technologies)** Series C · US · earth2tech.com **$76M** With 2 others
- **Nov** **[Radius Health](https://millionrounds.com/company/radius-health)** Series C · US · radiuspharm.mwnewsroom.com **$15M** With 6 others
- **Jul** **[Dicerna Pharmaceuticals](https://millionrounds.com/company/dicerna-pharmaceuticals)** Series A · US **$8.4M** With 2 others
- **Mar** **[BrainCells](https://millionrounds.com/company/braincells)** Series B · US · venturebeat.com **$30M** With 5 others
- **Jan** **[Laboratory Partners](https://millionrounds.com/company/laboratory-partners)** Series D · US · deals.venturebeat.com **$16M** With 2 others
- **2007** 14 rounds
- **Dec** **[Mitralign](https://millionrounds.com/company/mitralign)** Series C · US **$24M** With 7 others
- **Nov** **[Ensemble Discovery](https://millionrounds.com/company/ensemble-discovery)** Series B · US **$15M** With 6 others
- **Oct** **[Xencor](https://millionrounds.com/company/xencor)** Series E · US **$15M** With 2 others
- **Oct** **[Luca Technologies](https://millionrounds.com/company/luca-technologies)** Series B · US · earth2tech.com **$20M** With 2 others
- **Sept** **[Ceres](https://millionrounds.com/company/ceres)** Growth · US · ceres.net **$75M** With 8 others
- **Aug** **[BioProcessors](https://millionrounds.com/company/bioprocessors)** Series C · US **$10M** With 4 others
- **May** **[Intechra Holdings](https://millionrounds.com/company/intechra-holdings)** Series C · US · deals.venturebeat.com **$30M** With 4 others
- **Apr** **[CircuLite](https://millionrounds.com/company/circulite)** Series B · US **$5.0M** With 4 others
- **Apr** **[Coherex Medical](https://millionrounds.com/company/coherex-medical)** Series A · US **$8.5M** With 1 other
- **Apr** **[Radius Health](https://millionrounds.com/company/radius-health)** Series B · US · radiuspharm.com **$58M** With 5 others
- **Mar** **[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Series A · US **$18M** With 3 others
- **Mar** **[Tragara](https://millionrounds.com/company/tragara)** Series A · US **$40M** With 4 others
- **Jan** **[Claros Diagnostics](https://millionrounds.com/company/claros-diagnostics)** Series A · US **$7.8M** With 3 others
- **Jan** **[CircuLite](https://millionrounds.com/company/circulite)** Series B · US **$10M** With 1 other
- **2006** 4 rounds
- **Dec** **[Hydrocision](https://millionrounds.com/company/hydrocision)** Venture · US **$13M** With 2 others
- **Nov** **[Elixir Pharmaceuticals](https://millionrounds.com/company/elixir-pharmaceuticals)** Series C · US · deals.venturebeat.com **$46M** With 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **1** person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **23 in all**

**[Coherex Medical](https://millionrounds.com/company/coherex-medical)** Bought by Biosense Webster **Undisclosed** Nov 2015

**[Seahorse Bioscience](https://millionrounds.com/company/seahorse-bioscience)** Bought by [Agilent Technologies](https://millionrounds.com/fund/agilent-technologies) **$235M** Sept 2015

**[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Bought by [Debiopharm Group](https://millionrounds.com/fund/debiopharm-innovat) **Undisclosed** Feb 2014

**[Xencor](https://millionrounds.com/company/xencor)** Listed **$70M** Dec 2013

**[CircuLite](https://millionrounds.com/company/circulite)** Bought by HeartWare International **$30M** Dec 2013

**[ACADIA Pharmaceuticals](https://millionrounds.com/company/acadia-pharmaceuticals)** Listed **$115M** May 2013

**[Enanta Pharmaceuticals](https://millionrounds.com/company/enanta-pharmaceuticals)** Listed **$56M** Mar 2013

**[SuperDimension](https://millionrounds.com/company/superdimension)** Bought by [Covidien](https://millionrounds.com/fund/covidien) **$300M** Mar 2012

**[Claros Diagnostics](https://millionrounds.com/company/claros-diagnostics)** Bought by [OPKO Health](https://millionrounds.com/fund/opko-health) **Undisclosed** Oct 2011

**[Pathway Medical Technologies](https://millionrounds.com/company/pathway-medical-technologies)** Bought by MEDRAD **Undisclosed** Sept 2011

**[ImpactRx](https://millionrounds.com/company/impactrx)** Bought by [Symphony Technology Group](https://millionrounds.com/fund/symphony-technology-group) **Undisclosed** Apr 2011

**[Intechra Holdings](https://millionrounds.com/company/intechra-holdings)** Bought by [Arrow Electronics](https://millionrounds.com/fund/arrow-electronics) **Undisclosed** Dec 2010

**[Solstice Neurosciences](https://millionrounds.com/company/solstice-neurosciences)** Bought by US WorldMeds **$36M** Aug 2010

**[AVEO Pharmaceuticals](https://millionrounds.com/company/aveo-pharmaceuticals)** Listed **Undisclosed** Mar 2010

**[BioProcessors](https://millionrounds.com/company/bioprocessors)** Bought by Seahorse Bioscience **Undisclosed** Mar 2009

**[FlowMedica](https://millionrounds.com/company/flowmedica)** Bought by AngioDynamics **Undisclosed** Jan 2009

**[Xanthus Pharmaceuticals](https://millionrounds.com/company/xanthus-pharmaceuticals)** Bought by Antisoma **Undisclosed** May 2008

**[Critical Therapeutics,Inc.](https://millionrounds.com/company/critical-therapeutics-inc)** Bought by Cornerstone Therapeutics **Undisclosed** May 2008

**[Alantos Pharmaceuticals](https://millionrounds.com/company/alantos-pharmaceuticals)** Bought by [Amgen](https://millionrounds.com/fund/amgen) **Undisclosed** Jun 2007

**[Hypnion](https://millionrounds.com/company/hypnion)** Bought by Lilly **Undisclosed** Apr 2007

The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Series B Series C Series A

Median round joined **$15M** the round, not its cheque Alone, median **$2.0M**

Led 0 of 73 rounds **0%**

- **Sole investor:** 1 rounds
- **Last cheque:** May 2014
- **Exits:** 23 from the portfolio

Rounds by stage said on their site

- Series B *24*
- Series C *15*
- Series A *11*
- Series D *10*
- Venture *6*
- Growth *3*

Cheques by year Led Joined

2001 2014

Often in the room with

- [HealthCare Ventures](https://millionrounds.com/fund/healthcare-ventures-llc) 11
- [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 8
- [MPM Capital](https://millionrounds.com/fund/mpm-bioimpact) 7
- [MedImmune Ventures](https://millionrounds.com/fund/medimmune-ventures) 6
- [SV Life Sciences](https://millionrounds.com/fund/sv-life-sciences) 6
- [Medica Venture Partners](https://millionrounds.com/fund/medica-venture-partners) 5

**Pitching Oxford Bioscience Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Oxford Bioscience Partners. A count of rooms they were both in, not a relationship either has claimed.

[**HealthCare Ventures** Growth equity **11** rounds together](https://millionrounds.com/fund/healthcare-ventures-llc)[**ARCH Venture Partners** VC firm **8** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**MPM Capital** Private equity **7** rounds together](https://millionrounds.com/fund/mpm-bioimpact)[**MedImmune Ventures** Corporate VC **6** rounds together](https://millionrounds.com/fund/medimmune-ventures)[**SV Life Sciences** VC firm **6** rounds together](https://millionrounds.com/fund/sv-life-sciences)[**Medica Venture Partners** VC firm **5** rounds together](https://millionrounds.com/fund/medica-venture-partners)[**Forbion Capital Partners** Private equity **4** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**HLM Investment Partners** VC firm **4** rounds together](https://millionrounds.com/fund/hlm-investment-partners)[**Johnson & Johnson Development Corporation (JJDC)** VC firm **4** rounds together](https://millionrounds.com/fund/johnson-and-johnson-development-corporation)[**Kleiner Perkins Caufield & Byers** VC firm **4** rounds together](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers)[**ABN AMRO Fund** Corporate VC **3** rounds together](https://millionrounds.com/fund/abn-amro-clearing)[**Alloy Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/alloy-ventures)

## Quick answers about Oxford Bioscience Partners

### What does Oxford Bioscience Partners invest in?

Oxford Bioscience Partners invests most often at Series B and Series C (57% of the rounds on record), in sectors such as Information Technology and Logistics.

### How active is Oxford Bioscience Partners?

73 investments on record, 0 of them in the last 12 months. The most recent was in May 2014.

### How big are Oxford Bioscience Partners's cheques?

The median round it joins is $15M.

### Does Oxford Bioscience Partners lead rounds?

Rarely, if at all: none of its 73 investments on record names it as the lead.

### Where does Oxford Bioscience Partners invest?

Most of the companies it backs are in the United States (100%).

### Is Oxford Bioscience Partners investing now?

No investments in the last 12 months; the latest was in May 2014.

### Who does Oxford Bioscience Partners invest alongside?

Most often HealthCare Ventures (11 rounds together), ARCH Venture Partners (8 rounds together) and MPM Capital (7 rounds together).

### What kind of investor is Oxford Bioscience Partners?

Oxford Bioscience Partners is a growth equity firm based in United States.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=oxford-bioscience-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=oxford-bioscience-partners)